Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179868 · ClinicalTrials.gov registry record
C-Reactive Protein as a Predictor of Stem Cell Transplant Complications
A clinical trial of Cancer and Leukemia, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- 70
- Enrollment target
- 1
- Study location
NCT00179868 is a study of Cancer and Leukemia that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 70 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00179868, a study of Cancer and Leukemia, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if C-Reactive Protein levels are predictive for complications post transplant.
Conditions Studied
Interventions
- BEHAVIORAL C-Reactive Protein levels
Study Locations (1)
Illinois
- Children's Memorial Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2003-01 |
| Est. Completion | 2008-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00179868
The ClinicalTrials.gov registry entry for NCT00179868 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which C-Reactive Protein levels is the first listed.
NCT00179868 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00179868 about?
NCT00179868 is a clinical study titled "C-Reactive Protein as a Predictor of Stem Cell Transplant Complications". The purpose of this study is to determine if C-Reactive Protein levels are predictive for complications post transplant.
What is the current status of trial NCT00179868?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2003-01. Estimated completion is 2008-02.
What conditions does trial NCT00179868 study?
This clinical trial studies the following conditions: Cancer, Leukemia, Stem Cell Transplantation.
What interventions are being tested in trial NCT00179868?
The interventions under investigation include: C-Reactive Protein levels (BEHAVIORAL).
Who is sponsoring clinical trial NCT00179868?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00179868 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.